Another Step Toward the Cure of Metastatic Renal Cell Carcinoma?
Author:
Affiliation:
1. Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and US Oncology Research, Houston, TX
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.5044
Reference35 articles.
1. Treatment Options in Metastatic Renal Carcinoma: An Embarrassment of Riches
2. Multicenter Phase II Trial of S-1 in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
3. Management of renal cancer in the tyrosine kinase inhibitor era: a view from 3 years on
4. New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and Resistance
5. Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers;International Journal of Biological Sciences;2023
2. Survival outcomes for advanced kidney cancer patients in the era of targeted therapies;Annals of Translational Medicine;2018-05
3. The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes;Oncotarget;2017-05-09
4. Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases;Critical Reviews in Oncology/Hematology;2014-08
5. Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy;Molecular Cancer;2014-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3